Vycor Medical, Inc. (VYCO)
0.0672
0.00 (0.00%)
USD |
OTCM |
Sep 10, 16:00
Vycor Medical Debt to Equity Ratio : -0.2253 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2253 |
| March 31, 2026 | -0.2319 |
| December 31, 2025 | -0.2467 |
| September 30, 2025 | -0.2574 |
| June 30, 2025 | -0.2614 |
| March 31, 2025 | -0.2642 |
| December 31, 2024 | -0.2866 |
| September 30, 2024 | -0.294 |
| June 30, 2024 | -0.3008 |
| March 31, 2024 | -0.3078 |
| December 31, 2023 | -0.3338 |
| September 30, 2023 | -0.3504 |
| June 30, 2023 | -0.3133 |
| March 31, 2023 | -0.3124 |
| December 31, 2022 | -0.338 |
| September 30, 2022 | -0.3406 |
| June 30, 2022 | -0.3482 |
| March 31, 2022 | -0.3574 |
| December 31, 2021 | -0.3623 |
| September 30, 2021 | -0.3975 |
| June 30, 2021 | -0.4536 |
| March 31, 2021 | -0.445 |
| December 31, 2020 | -0.4881 |
| September 30, 2020 | -0.5236 |
| June 30, 2020 | -0.5027 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.5074 |
| December 31, 2019 | -0.4333 |
| September 30, 2019 | -0.4779 |
| June 30, 2019 | -0.5742 |
| March 31, 2019 | -0.6387 |
| December 31, 2018 | -0.6748 |
| September 30, 2018 | -1.286 |
| June 30, 2018 | -2.027 |
| March 31, 2018 | -1.287 |
| December 31, 2017 | 3.912 |
| September 30, 2017 | 0.816 |
| June 30, 2017 | 0.3711 |
| March 31, 2017 | 0.4411 |
| December 31, 2016 | -25.22 |
| September 30, 2016 | 1.459 |
| June 30, 2016 | 0.7559 |
| March 31, 2016 | 0.3732 |
| December 31, 2015 | 0.2756 |
| September 30, 2015 | 0.219 |
| June 30, 2015 | 0.1606 |
| March 31, 2015 | 0.1402 |
| December 31, 2014 | 0.1114 |
| September 30, 2014 | 0.1029 |
| June 30, 2014 | 1.794 |
| March 31, 2014 | -10.91 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Abbott Laboratories | 0.638 |
| AngioDynamics, Inc. | 0.0641 |
| Alphatec Holdings, Inc. | 52.37 |
| AtriCure, Inc. | 0.1437 |
| Baxter International, Inc. | 1.427 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.8132M |
| Total Liabilities (Quarterly) | 5.064M |
| Shareholders Equity (Quarterly) | -4.251M |
| Current Ratio | 0.129 |
| Net Debt Paydown Yield | 0.64% |